The first GWAS for pancreatic cancer, published in Nature Genetics in August 2009, identified common risk variants that map to the first intron of the ABO gene on chromosome 9q34.2 (SNP rs505922).11 This finding implies that people with blood group O may have a lower risk than those with groups A or B. This evidence concerns the gene ABO and pancreatic neoplasm.